These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18611086)

  • 1. Assessing secondary prevention methods for cervical cancer: costs and benefits in managed care.
    MacDonald CF
    Am J Manag Care; 2008 Jun; 14(6 Suppl 1):S185-92. PubMed ID: 18611086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic disparities in cervical cancer illness burden and subsequent care: a prospective view in managed care.
    Smith JS
    Am J Manag Care; 2008 Jun; 14(6 Suppl 1):S193-9. PubMed ID: 18611087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing new technologies for cervical cancer screening: beyond sensitivity.
    Massad LS
    J Low Genit Tract Dis; 2008 Oct; 12(4):311-5. PubMed ID: 18820547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
    Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the short-term and long-term burden of illness in cervical cancer.
    Lipsy RJ
    Am J Manag Care; 2008 Jun; 14(6 Suppl 1):S177-84. PubMed ID: 18611085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative cervical cancer prevention in low-resource settings: Experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
    Palanuwong B
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):54-60. PubMed ID: 17261102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and outcome of cervical cancer prevention failures in the United States.
    Raab SS; Grzybicki DM; Zarbo RJ; Jensen C; Geyer SJ; Janosky JE; Meier FA; Vrbin CM; Carter G; Geisinger KR
    Am J Clin Pathol; 2007 Nov; 128(5):817-24. PubMed ID: 17951205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis.
    Rogoza RM; Ferko N; Bentley J; Meijer CJ; Berkhof J; Wang KL; Downs L; Smith JS; Franco EL
    Vaccine; 2008 Sep; 26 Suppl 5():F46-58. PubMed ID: 18992382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cervical cancer.
    Denny L
    Reprod Health Matters; 2008 Nov; 16(32):18-31. PubMed ID: 19027619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making the case for cervical cancer prevention: what about equity?
    Tsu VD; Levin CE
    Reprod Health Matters; 2008 Nov; 16(32):104-12. PubMed ID: 19027628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing cervical cancer: the Pap test and the HPV vaccine.
    Waxman AG; Zsemlye MM
    Med Clin North Am; 2008 Sep; 92(5):1059-82, x. PubMed ID: 18721653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low cost methods for secondary prevention of cervical cancer in developing countries.
    Anorlu RI; Ola ER; Abudu OO
    Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.